These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

829 related items for PubMed ID: 27339889

  • 1. Pharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus.
    Tahrani AA, Barnett AH, Bailey CJ.
    Nat Rev Endocrinol; 2016 Oct; 12(10):566-92. PubMed ID: 27339889
    [Abstract] [Full Text] [Related]

  • 2. Glycemic control of type 2 diabetes mellitus across stages of renal impairment: information for primary care providers.
    Tong L, Adler S.
    Postgrad Med; 2018 May; 130(4):381-393. PubMed ID: 29667921
    [Abstract] [Full Text] [Related]

  • 3. Complementing insulin therapy to achieve glycemic control.
    Barnett AH.
    Adv Ther; 2013 Jun; 30(6):557-76. PubMed ID: 23797471
    [Abstract] [Full Text] [Related]

  • 4. Cardiovascular benefits and safety of non-insulin medications used in the treatment of type 2 diabetes mellitus.
    Yandrapalli S, Jolly G, Horblitt A, Sanaani A, Aronow WS.
    Postgrad Med; 2017 Nov; 129(8):811-821. PubMed ID: 28749197
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Diabetes Update: New Pharmacotherapy for Type 2 Diabetes.
    Choby B.
    FP Essent; 2017 May; 456():27-35. PubMed ID: 28530382
    [Abstract] [Full Text] [Related]

  • 7. Bodyweight changes associated with antihyperglycaemic agents in type 2 diabetes mellitus.
    Hermansen K, Mortensen LS.
    Drug Saf; 2007 May; 30(12):1127-42. PubMed ID: 18035865
    [Abstract] [Full Text] [Related]

  • 8. EMPA-REG and Other Cardiovascular Outcome Trials of Glucose-lowering Agents: Implications for Future Treatment Strategies in Type 2 Diabetes Mellitus.
    Schernthaner G, Schernthaner-Reiter MH, Schernthaner GH.
    Clin Ther; 2016 Jun; 38(6):1288-1298. PubMed ID: 27210264
    [Abstract] [Full Text] [Related]

  • 9. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ, Bailey CJ.
    Drugs; 2005 Jun; 65(3):385-411. PubMed ID: 15669880
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Add-on therapy in metformin-treated patients with type 2 diabetes at moderate cardiovascular risk: a nationwide study.
    Thein D, Christiansen MN, Mogensen UM, Bundgaard JS, Rørth R, Madelaire C, Fosbøl EL, Schou M, Torp-Pedersen C, Gislason G, Køber L, Kristensen SL.
    Cardiovasc Diabetol; 2020 Jul 06; 19(1):107. PubMed ID: 32631337
    [Abstract] [Full Text] [Related]

  • 15. The treatment of type 1 diabetes mellitus with agents approved for type 2 diabetes mellitus.
    Munir KM, Davis SN.
    Expert Opin Pharmacother; 2015 Jul 06; 16(15):2331-41. PubMed ID: 26340427
    [Abstract] [Full Text] [Related]

  • 16. A Review of Cardiovascular Outcomes Trials of Glucose-Lowering Therapies and Their Effects on Heart Failure Outcomes.
    Nassif ME, Kosiborod M.
    Am J Cardiol; 2019 Dec 15; 124 Suppl 1():S12-S19. PubMed ID: 31741435
    [Abstract] [Full Text] [Related]

  • 17. Evolving therapeutic options for type 2 diabetes mellitus: an overview.
    Guthrie RM.
    Postgrad Med; 2012 Nov 15; 124(6):82-9. PubMed ID: 23322141
    [Abstract] [Full Text] [Related]

  • 18. Pharmacologic Management of Type 2 Diabetes Mellitus: Available Therapies.
    Thrasher J.
    Am J Cardiol; 2017 Jul 01; 120(1S):S4-S16. PubMed ID: 28606343
    [Abstract] [Full Text] [Related]

  • 19. Network meta-analysis of treatments for type 2 diabetes mellitus following failure with metformin plus sulfonylurea.
    Lozano-Ortega G, Goring S, Bennett HA, Bergenheim K, Sternhufvud C, Mukherjee J.
    Curr Med Res Opin; 2016 May 01; 32(5):807-16. PubMed ID: 26700585
    [Abstract] [Full Text] [Related]

  • 20. Oral combination therapy in primary care.
    Kalra S, Gupta Y.
    J Pak Med Assoc; 2015 May 01; 65(5):574-5. PubMed ID: 26028398
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.